DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET

被引：0
|
作者：
Werner, Jan-Michael [1 ,2 ]
Ceccon, Garry [1 ,2 ]
Weller, Johannes [3 ]
Schaub, Christina [3 ]
Tscherpel, Caroline [1 ,2 ]
Lohmann, Philipp [4 ]
Bauer, Elena [1 ,2 ]
Schaefer, Niklas [3 ]
Stoffels, Gabriele [4 ]
Kabbasch, Christoph [2 ,5 ]
Baues, Christian [2 ,6 ]
Marnitz, Simone [2 ,6 ]
Fink, Gereon R. [1 ,2 ]
Langen, Karl-Josef [4 ]
Herrlinger, Ulrich [3 ]
Galldiks, Norbert [1 ,2 ]
机构：
[1] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Univ Hosp Bonn, Dept Neurol, Div Clin Neurooncol, Bonn, Germany
[4] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany
[5] Univ Cologne, Fac Med, Dept Neuroradiol, Cologne, Germany
[6] Univ Cologne, Fac Med, Dept Radiat Oncol, Cologne, Germany
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NIMG-26
引用
收藏
页码：152 / 153
页数：3
相关论文
共 50 条
  • [1] Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
    Werner, Jan-Michael
    Weller, Johannes
    Ceccon, Garry
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena K.
    Schaefer, Niklas
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Marnitz, Simone
    Kabbasch, Christoph
    Gielen, Gerrit H.
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3704 - 3713
  • [2] ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET
    Werner, Jan-Michael
    Wollring, Michael M.
    Tscherpel, Caroline
    Rosen, Elena K.
    Ceccon, Garry
    Stetter, Isabelle
    Lohmann, Philipp
    Weller, Johannes
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Mottaghy, Felix M.
    Goldbrunner, Roland
    Herrlinger, Ulrich
    Fink, Gereon R.
    Langen, Karl-Josef
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2024, 26
  • [3] ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET
    Werner, J.
    Wollring, M. M.
    Tscherpel, C.
    Rosen, E. K.
    Ceccon, G.
    Stetter, I
    Lohmann, P.
    Weller, J.
    Stoffels, G.
    Baues, C.
    Celik, E.
    Mottaghy, F. M.
    Goldbrunner, R.
    Herrlinger, U.
    Fink, G. R.
    Langen, K.
    Galldiks, N.
    NEURO-ONCOLOGY, 2024, 26 : V50 - V50
  • [4] Lomustine-temozolomide combination efficacious in newly diagnosed glioblastoma
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (05) : 273 - 273
  • [5] Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
    Herrlinger, Ulrich
    Rieger, Johannes
    Koch, Dorothee
    Loeser, Simon
    Blaschke, Britta
    Kortmann, Rolf-Dieter
    Steinbach, Joachim P.
    Hundsberger, Thomas
    Wick, Wolfgang
    Meyermann, Richard
    Tan, Ta-Chih
    Sommer, Clemens
    Bamberg, Michael
    Reifenberger, Guido
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4412 - 4417
  • [6] Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
    Schiff, David
    Huse, Jason
    Wen, Patrick
    NEURO-ONCOLOGY, 2014, 16 (06) : 769 - 769
  • [7] Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
    Chinot, Olivier L.
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Carpentier, Antoine F.
    Hoang-Xuan, Khe
    Kavan, Petr
    Cernea, Dana
    Brandes, Alba A.
    Hilton, Magalie
    Abrey, Lauren
    Cloughesy, Timothy
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (08): : 709 - 722
  • [8] The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
    Sidsel Højklint Poulsen
    Thomas Urup
    Kirsten Grunnet
    Ib Jarle Christensen
    Vibeke Andrée Larsen
    Michael Lundemann Jensen
    Per Munck af Rosenschöld
    Hans Skovgaard Poulsen
    Ian Law
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 373 - 381
  • [9] The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
    Poulsen, Sidsel Hojklint
    Urup, Thomas
    Grunnet, Kirsten
    Christensen, Ib Jarle
    Larsen, Vibeke Andree
    Jensen, Michael Lundemann
    af Rosenschold, Per Munck
    Poulsen, Hans Skovgaard
    Law, Ian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (03) : 373 - 381
  • [10] Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma
    Wick, Wolfgang
    Chinot, Olivier L.
    Bendszus, Martin
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Revil, Cedric
    Kerloeguen, Yannick
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2016, 18 (10) : 1434 - 1441
12345